Economic Times

Business Standard

Ø  RBI surprises with no rate cut: Key takeaways

Ø  RBI to withdraw temporary cash reserve ratio hike

Ø  NITI Aayog pulled up for slacking on 12th Five Year Plan

Ø  IOC, BPCL, HPCL to set up India's biggest refinery

Ø  India to be less affected by Trump's US policy: S&P

Ø  Telcos' revenues may slip 7% post RJio offer



Ø  Demonetisation: A month after move, 65% currency remains unreplaced

Ø  Inflation, Dollar, notes: Takeaways from the RBI's Monetary Policy review

Ø  Sun Pharma says US FDA finds more concerns at Halol plant

Ø  Govt seeks to increase net spending by $5.2 billion for FY17

Ø  RBI sets rupee reference rate at 67.8707 against US dollar

Ø  Centre mulls scrapping wheat import duty to boost supplies

Business Line



Mint

Ø  Foxconn confirms US investment talks after Trump boast 

Ø  SBT to raise Rs. 600 cr via Basel-III bonds

Ø  Suven Life gets product patent for neuro-degenerative drug

Ø  NeuroEquilibrium raises $250,000 seed funding 

Ø  Ashoka Buildcon bags rural electrification contract in Bihar 



Ø  Britain fines Pfizer record $107 million for huge drug price hike

Ø  Goldman Sachs slashes India’s growth estimates amid demonetisation

Ø  Sebi working on norms for instant redemption of liquid mutual funds

Ø  Niti Aayog said to recommend tax breaks for digital payments

Financial Express



Financial Chronicle

Ø  Tata Steel commits 10-year investment plan for UK

Ø  PSU banks write off Rs 1.54 lakh crore bad loans

Ø  Asian shares edge up as markets look to ECB after Italian vote

Ø  Yamaha Motor, Fuji Heavy Industries conclude contract to transfer of US technological assets



Ø  RBI cuts growth forecast to 7.1%, sees short-term disruption

Ø  Demonetisation to impact activities in cash-intensive sectors

Ø  Paytm launches payments method for non-internet users

Ø  UK MP calls on India to end demonetisation stress for NRIs

Ø  Bonus issuance by PSUs has stocks surging by up to 70%